DOES IRON PLAY A ROLE IN PARKINSONS-DISEASE

被引：14
|
作者：
BAUMINGER, ER
BARCIKOWSKA, M
FRIEDMAN, A
GALAZKAFRIEDMAN, J
HECHEL, D
NOWIK, I
机构：
[1] MED ACAD WARSAW,DEPT NEUROL,WARSAW,POLAND
[2] WARSAW UNIV TECHNOL,INST PHYS,WARSAW,POLAND
来源：
HYPERFINE INTERACTIONS | 1994年 / 91卷 / 1-4期
关键词：
D O I：
10.1007/BF02064618
中图分类号：
O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号：
070203 ; 070304 ; 081704 ; 1406 ;
摘要：
Mossbauer studies of Parkinsonian and control Substantia Nigra (SN) show that the overall amount of iron in SN is about the same in PD and control. At least 90% of this iron is ferritin-like and Fe2+ and/or neuromelanin iron, if present at all, can constitute only less than 10% of the overall iron. During storage in formalin, iron is slowly removed from ferritin and bound to a chelating agent.
引用
收藏
页码：853 / 857
页数：5
相关论文
共 50 条
  • [41] THE ROLE OF PHYSICAL EXERCISE IN THE OCCURRENCE OF PARKINSONS-DISEASE
    SASCO, AJ
    PAFFENBARGER, RS
    GENDRE, I
    WING, AL
    ARCHIVES OF NEUROLOGY, 1992, 49 (04) : 360 - 365
  • [42] THE ROLE OF ENVIRONMENTAL TOXINS IN THE ETIOLOGY OF PARKINSONS-DISEASE
    TANNER, CM
    TRENDS IN NEUROSCIENCES, 1989, 12 (02) : 49 - 54
  • [43] ROLE OF MITOCHONDRIA IN THE ETIOLOGY AND PATHOGENESIS OF PARKINSONS-DISEASE
    MIZUNO, Y
    IKEBE, S
    HATTORI, N
    NAKAGAWAHATTORI, Y
    MOCHIZUKI, H
    TANAKA, M
    OZAWA, T
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1271 (01): : 265 - 274
  • [44] THERAPY IN PARKINSONS-DISEASE - ROLE OF ANTICHOLINERGICS AND AMANTADINES
    SCHNEIDER, E
    AKTUELLE NEUROLOGIE, 1988, 15 (02) : 35 - 37
  • [45] LEVODOPA DOES NOT AGGRAVATE POSTURAL TREMOR IN PARKINSONS-DISEASE
    KULISEVSKY, J
    AVILA, A
    BARBANOJ, M
    ANTONIJOAN, R
    TORRES, J
    ARCELUS, R
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 (05) : 435 - 442
  • [46] A MECHANISM FOR PATHOLOGICAL GLIAL IRON SEQUESTRATION IN PARKINSONS-DISEASE
    SCHIPPER, HM
    WANG, X
    MANGANARO, F
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 327 - 327
  • [47] IRON HISTOCHEMISTRY OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    MORRIS, CM
    EDWARDSON, JA
    NEURODEGENERATION, 1994, 3 (04): : 277 - 282
  • [48] POSSIBLE ROLE OF NEUROMELANIN IN THE PATHOGENESIS OF PARKINSONS-DISEASE
    MANN, DMA
    YATES, PO
    MECHANISMS OF AGEING AND DEVELOPMENT, 1983, 21 (02) : 193 - 203
  • [49] DOES AN ENDOGENOUS METHYLPYRIDINIUM ANALOG CAUSE PARKINSONS-DISEASE
    TESTA, B
    NAYLOR, R
    COSTALL, B
    JENNER, P
    MARSDEN, CD
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (09) : 679 - 680
  • [50] SLEEP IN PARKINSONS-DISEASE - THE ROLE OF DEPRESSION AND ANXIETY
    MENZA, MA
    ROSEN, RC
    PSYCHOSOMATICS, 1995, 36 (03) : 262 - 266
12345